Spire Healthcare Group (LON:SPI) Stock Price Up 14.1% - Still a Buy?

Key Points

• Spire Healthcare Group's stock price rose by 14.1%, reaching a high of GBX 256.50 ($3.46) on Saturday after trading significantly above the average daily volume.
• Analysts have issued a consensus "Buy" rating for the stock, with a target price of approximately GBX 294.33, despite some differing price targets from major financial institutions.
• The company reported earnings of GBX 4.10 per share for the previous quarter, alongside projections for a total of 15.66 earnings per share for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report)'s stock price rose 14.1% during trading on Saturday . The stock traded as high as GBX 256.50 ($3.47) and last traded at GBX 247 ($3.34). Approximately 9,747,062 shares traded hands during trading, an increase of 563% from the average daily volume of 1,469,073 shares. The stock had previously closed at GBX 216.50 ($2.93).

Analyst Ratings Changes

Several equities analysts recently weighed in on SPI shares. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 280 price objective on shares of Spire Healthcare Group in a research note on Thursday, July 31st. JPMorgan Chase & Co. lowered their target price on Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating on the stock in a report on Tuesday, August 5th. Three investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of GBX 294.33.

Spire Healthcare Group Price Performance

The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The firm has a market capitalization of £947.58 million, a PE ratio of 5,119.57, a P/E/G ratio of 1.06 and a beta of 0.96. The company has a 50-day moving average price of GBX 218.99 and a 200-day moving average price of GBX 203.96.

Spire Healthcare Group (LON:SPI - Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. Sell-side analysts forecast that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.